BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 16579943)

  • 1. Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms.
    Wu JM; Williams KS; Hundley AF; Jannelli ML; Visco AG
    Am J Obstet Gynecol; 2006 May; 194(5):1423-6. PubMed ID: 16579943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of urinary cytology in women presenting with urge incontinence and/or irritative voiding symptoms.
    Duldulao KE; Diokno AC; Mitchell B
    J Urol; 1997 Jan; 157(1):113-6. PubMed ID: 8976229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of urine cytology testing and cystoscopy in women with irritative voiding symptoms.
    Sokol ER; Patel SR; Sung VW; Rardin CR; Weitzen S; Clemons JL; Myers DL
    Am J Obstet Gynecol; 2005 May; 192(5):1560-5. PubMed ID: 15902158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and monitoring for bladder cancer: refining the use of NMP22.
    Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD
    J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective assessment of overactive bladder symptoms in a cohort of elderly women who underwent transvaginal surgery for advanced pelvic organ prolapse.
    Foster RT; Barber MD; Parasio MF; Walters MD; Weidner AC; Amundsen CL
    Am J Obstet Gynecol; 2007 Jul; 197(1):82.e1-4. PubMed ID: 17618768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of urinary cytology testing in the evaluation of irritative voiding symptoms.
    Sokol ER; Patel SR; Clemons JL; Sung VW; Rardin CR; Myers DL
    Am J Obstet Gynecol; 2005 May; 192(5):1554-9. PubMed ID: 15902157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical symptoms predictive of recurrent urinary tract infections.
    Gopal M; Northington G; Arya L
    Am J Obstet Gynecol; 2007 Jul; 197(1):74.e1-4. PubMed ID: 17618765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictability of irritative voiding symptoms following photoselective laser vaporization of the prostate.
    Matoka DJ; Averch TD
    Can J Urol; 2007 Oct; 14(5):3710-4. PubMed ID: 17949529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of bladder biopsy to the study of urogynaecological patient].
    Flores-Carreras O; Martínez-Espinoza CJ; González-Ruiz MI; Montes-Casillas YE
    Ginecol Obstet Mex; 2010 Mar; 78(3):187-90. PubMed ID: 20939223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
    Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
    J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can hematuria be a predictor as well as a symptom or sign of bladder cancer?
    Friedman GD; Carroll PR; Cattolica EV; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):993-6. PubMed ID: 8959322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.
    Goh AC; Tresser NJ; Shen SS; Lerner SP
    Urology; 2008 Jul; 72(1):133-7. PubMed ID: 18598789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection.
    Lotan Y; Shariat SF;
    BJU Int; 2008 Jun; 101(11):1362-7. PubMed ID: 18284410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urgency is the core symptom of female overactive bladder syndrome, as demonstrated by a statistical analysis.
    Hung MJ; Ho ES; Shen PS; Sun MJ; Lin AT; Chen GD;
    J Urol; 2006 Aug; 176(2):636-40. PubMed ID: 16813910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of benign microscopic hematuria among women with interstitial cystitis: implications for evaluation of genitourinary malignancy.
    Stanford EJ; Mattox TF; Parsons JK; McMurphy C
    Urology; 2006 May; 67(5):946-9. PubMed ID: 16635517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of computed tomographic urography for the detection of bladder tumors in patients with microscopic hematuria.
    Aguilar-Davidov B; Ramírez-Muciño A; Culebro-García C; Sotomayor M; Castillejos-Molina R; Feria-Bernal G; Rodríguez-Covarrubias F
    Actas Urol Esp; 2013; 37(7):408-11. PubMed ID: 23398811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice.
    Khadra MH; Pickard RS; Charlton M; Powell PH; Neal DE
    J Urol; 2000 Feb; 163(2):524-7. PubMed ID: 10647670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis.
    Tissot WD; Diokno AC; Peters KM
    J Urol; 2004 Aug; 172(2):478-80. PubMed ID: 15247708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transurethral incision of the bladder neck using KTP in the treatment of bladder neck obstruction in women.
    Fu Q; Xu YM
    Urol Int; 2009; 82(1):61-4. PubMed ID: 19172099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.